Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Insulin detemir offers improved predictability and control in basal bolus insulin therapy

April 9, 2003

Alizyme scientists describe novel lipase inhibitors for obesity and related disorders

April 9, 2003

Cathepsin K inhibitors under study at Novartis

April 9, 2003

Novel PPARalpha agonists identified by Aventis researchers

April 9, 2003

Nippon Chemiphar claims PPARdelta agonists with utility in metabolic disorders

April 8, 2003

Aventis presents four related series of anorectic compounds

April 8, 2003

New PTP1B inhibitors in early development at Abbott

April 8, 2003

Pharmacokinetics of HBOC-201 in surgical patients

April 8, 2003

E.U. approval for NeoRecormon use once every two weeks for renal anemia

April 7, 2003

Novel antidiabetic PPAR modulators discovered by Pfizer researchers

April 4, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.